TITLE

Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern

AUTHOR(S)
Jha, Hem C.; Vardhan, Harsh; Gupta, Rishein; Varma, Rakesh; Prasad, Jagdish; Mittal, Aruna
PUB. DATE
January 2007
SOURCE
BMC Infectious Diseases;2007, Vol. 7 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: There is growing evidence that Chlamydia pneumoniae may be involved in the pathogenesis of atherosclerosis, as several studies have demonstrated the presence of the organism in atherosclerotic lesions. C. pneumoniae infections, which are especially persistent infections, have been difficult to diagnose either by serological methods or isolation of the organism from the tissue. Nucleic Acid Amplification tests (NAATs) has emerged as an important method for detecting C. pneumoniae. Inspite of high prevalence of C. pneumoniae specific antibodies in coronary heart disease patients, direct detection of C. pneumoniae in circulating blood of coronary artery disease (CAD) patients by sensitive nucleic acid amplification tests nested PCR (nPCR), multiplex PCR (mPCR) has not been carried out is required. Further correlation of the presence of C. pneumoniae in blood of CAD patients with C. pneumoniae specific IgA and IgG antibodies, which may indicative of the status of infection with the progression of atherosclerosis. This will help in order to prepare strategies for the antibiotic intervention to avoid the progression towards CAD. Methods: Venous blood was obtained from 91 CAD patients and 46 healthy controls. Nucleic acid amplification tests viz. nested -, semi-nested - and multiplex PCR were used for detection of C. pneumoniae. ELISA carried out prevalence of C. pneumoniae specific IgG and IgA antibodies. Results: 29.67% (27/91) patients were positive for C. pneumoniae using nested PCR. The sensitivity and specificity of semi-nested and multiplex PCR were 37.03%, 96.96% and 22.22%, 100% with respect to nested PCR. Positive nPCR patients were compared with presence of C. pneumoniae specific IgA, IgA+IgG and IgG antibodies. Among 27 (29.67%) nPCR C. pneumoniae positive CAD patients, 11(12%) were IgA positive, 13(14.2%) were IgA+IgG positive and only1 (1.1%) was IgG positive. A significant presence of C. pneumoniae was detected in heavy smokers, non-alcoholics and with family histories of diabetes and blood pressure group of CAD patients by nPCR. Conclusion: The results indicate synergistic association of C. pneumoniae infection and development of CAD with other risk factors. We also detected increased positivity for C. pneumoniae IgA than IgG in nPCR positive CAD patients. Positive nPCR findings in conjunction with persisting high C. pneumoniae specific antibody strongly suggest an ongoing infection.
ACCESSION #
28796468

 

Related Articles

  • Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Dart, A.M.; Martin, J.L.; Kay, S. // International Journal of Obesity & Related Metabolic Disorders;Apr2002, Vol. 26 Issue 4, p464 

    Investigates the association between Chlamydia pneumoniae infection history and coronary heart disease (CHD) risk factors. Body mass index; Prevalence of seropositivity for subjects with and without CHD; Fasting insulin level; Low-density-lipoprotein particles.

  • Detection of Chlamydia pneumoniae within Peripheral Blood Monocytes of Patients with Unstable Angina or Myocardial Infarction. Maass, Matthias; Jahn, Jurgen; Gieffers, Jens; Dalhoff, Klaus; Katus, Hugo A.; Solbach, Werner // Journal of Infectious Diseases;6/15/2000 Supplement 3, Vol. 181, pS449 

    Presents a study that uses polymerase chain reaction detection of chlamydial DNA applied to cells from patients with angiographically identified unstable angina or acute myocardial infarction. Presence of Chlamydia pneumoniae in monocytes/macrophages of a significant proportion of persons with...

  • 153-7. BACTERIAL CAUSE FOR CHD?  // Cortlandt Forum;11/25/2000, Vol. 13 Issue 11, p83 

    Provides information on the possibility that bacterial infection, particularly with Chlamydia pneumoniae, causes coronary heart disease (CHD).

  • Relation of Chlamydia Pneumoniae Infection to Documented Coronary Artery Disease in Shiraz, Southern Iran. Zibaeenezhad, Mohammad Javad; Amanat, A.; Alborzi, A.; Obudi, A. // Angiology;Jan/Feb2005, Vol. 56 Issue 1, p43 

    The possibility that infectious agents may trigger a cascade of reactions leading to inflammation, atherogenesis, and vascular thrombotic events has recently been raised. Chlamydia pneumonias is one of those that have received the most investigative attention with respect to coronary artery...

  • Annals of Internal Medicine. Saikku, Pekka; Leinonen, Maija; Tenkanen, Leena; Linnanmaki, Eila; Ekman, Marja-Riitta; Manninen, Vesa; Manttari, Matti; Frick, M. Heikki; Huttunen, Jussi K. // Annals of Internal Medicine;2/15/92, Vol. 116 Issue 4, p273 

    Presents information on a study which investigated whether chronic Chlamydia pneumoniae infection is a risk factor for coronary heart disease in the Helsinki Heart Study in Finland. Information on the pathogen Chlamydia pneumoniae; Description of the design and results of the heart study;...

  • Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials. Higgins, John P. // Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p321 

    Discusses the potential role of Chlamydia pneumoniae infection in atherosclerosis. Randomized clinical trials of antichlamydial antibiotics in patients with coronary heart disease; Detection of infection; Four classes of antibiotics against infection; Specific factors that may link Chlamydia...

  • Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae. Padmavati, S.; Gupta, U.; Agarwal, H. K. // Indian Journal of Medical Research;Feb2012, Vol. 135 Issue 2, p228 

    Background & objectives: Studies on cardiovascular diseases (CVD) in India have shown about 10-20 per cent of cases with no obvious risk factors, raising a suspicion of infections as a cause. There is a paucity of data on this possible role of infections. This study was, therefore, undertaken to...

  • Growth in Vascular Cells and Cytokine Production by Chlamydia pneumoniae. Gaydos, Charlotte A. // Journal of Infectious Diseases;6/15/2000 Supplement 3, Vol. 181, pS473 

    Proposes the need for studies to learn the relationship between productive infection and persistence, the ability of Chlamydia pneumoniae to affect the immune response, and the potential for C. pneumoniae to influence atheromatous lesions. Proposed pathogenesis of C. pneumoniae in...

  • Cell-to-Cell Contact of Human Monocytes with Infected Arterial Smooth-Muscle Cells Enhances Growth of Chlamydia pneumoniae. Puolakkainen, Mirja; Ann Campbell, Lee; Tsun-Mei Lin; Richards, Theresa; Patton, Dorothy L.; Cho-Chou Kuo // Journal of Infectious Diseases;2/1/2003, Vol. 187 Issue 3, p435 

    Chlamydia pneumoniae can infect arterial cells. It has been shown that coculture of human monocytes (U937) and endothelial cells promotes infection of C. pneumoniae in endothelial cells and that the enhancement was mediated by a soluble factor (insulin-like growth factor 2) secreted by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics